Sign up
Quantellect · Congress · Trade Detail
NYSE: PFEPfizer Inc
RepublicanSenate

John Hoeven sold Pfizer Inc (NYSE: PFE)

John Hoeven (R-ND), a U.S. Senator, has disclosed 3 trades in Pfizer Inc (PFE) since 2013, 2 purchases and 1 sale, worth an estimated $158K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: John Hoeven sold $50,001 - $100,000 of Pfizer Inc (NYSE: PFE) on January 20, 2017. Since that trade, PFE is up +27.89% against the S&P 500 up +272.63%, an outperformance of -244.74%.

Across these filings, John Hoeven has been a net buyer of PFE (a buy-to-sell ratio of 2.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PFE trades
3
Disclosed Vol
$158K
Buys
2
67%
Sells
1
33%
Buy / Sell
2.00
ratio
First → Last
2013–2017

John Hoeven's PFE trades vs the price

PFE is up +27.89% since John Hoeven sold on January 20, 2017, versus +272.63% for the S&P 500.

Performance since this trade

Price change since trade
+27.89%
S&P 500 change since trade
+272.63%
Outperformance vs S&P 500
-244.74%

All John Hoeven PFE trades

TradedTypeSizeReturnEst. profit
January 20, 2017SELL$19.67+27.89%
November 25, 2016BUY$19.62+28.21%-$15K
February 27, 2013BUY$14.92+68.59%-$660

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

John Hoeven & PFE trading FAQ

Is it legal for John Hoeven to trade Pfizer Inc (PFE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Pfizer Inc (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did John Hoeven sell PFE?

John Hoeven disclosed a sale of $50,001 - $100,000 of Pfizer Inc (PFE) on January 20, 2017, according to public STOCK Act filings.

How has PFE performed since John Hoeven's trade?

Since John Hoeven sold PFE on January 20, 2017, the stock is up +27.89%, versus +272.63% for the S&P 500 over the same period, an outperformance of -244.74%.

How many times has John Hoeven traded PFE?

John Hoeven has disclosed 3 PFE trades since 2013 (2 purchases and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PFE trades?

Quantellect tracks every disclosed congressional trade in Pfizer Inc (PFE) on the Pfizer Inc congressional trading page, which aggregates filings across all members of Congress.

John Hoeven's PFE tradesAll congressional filings for Pfizer IncJohn Hoeven's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.